Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Reexamination Certificate
2007-10-16
2007-10-16
Nashed, Nashaat T. (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
C514S675000, 63
Reexamination Certificate
active
10730555
ABSTRACT:
The present invention relates to methods of treatingMycobacteriumpathogen infection in a subject that involve: inhibiting proteasomal activity in a pathogen under conditions effective to make the pathogen susceptible to antibacterial host defenses; inhibiting enzyme activity in a pathogen under conditions effective to make the pathogen susceptible to antibacterial host defenses, where the enzyme is a DNA repair enzyme or a flavin-like co-factor synthesis enzyme, or inhibiting proteasomal and enzyme activity under conditions to make the pathogen susceptible to antibacterial host defenses. The present invention also relates to methods for screening compounds that inhibit proteasomal and protease activity, DNA repair enzyme activity, or flavin-like co-factor synthesis enzyme activity, where the inhibitory compounds have an ability to sensitize bacteria to the antibacterial effects of oxidative
itrosative stress.
REFERENCES:
Schubert et al., Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2, Nov. 2000, PNAS, vol. 97, pp. 13057-13062.
J. Adams, 2002, “Proteasome inhibitors as new anticancer drugs”, Current Opinion in Oncology, vol. 14, pp. 626-634.
Bair et al., 2001, “Structures of coenzyme F240 in Mycobacterium species”, Archives of Microbiology, vol. 176, pp. 37-43.
Baumeister et al., 1998, “The proteasome: paradigm of a self-compartmentalizing protease”, Cell, vol. 92, pp. 367-380.
Elofsson et al., 1999, “Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide [alpha[,[beta]- epoxyketones”, Chemistry & Biology, vol. 6, pp. 811-822.
Freidberg et al., Eds., 1995, “Nucleotide excision repair in prokaryotes”, in DNA Repair and Mutagenesis, ASM Press, pp. 191-232.
Isabelle et al., 2002, “Large-scale production of Coenzyme F420-5,6 usingMycobacteriaum smegmatis”, Applied and Environmental Microbiology, vol. 68, pp. 5750-5755.
Lowe et al., 1995, “Crystal structure of the 20S proteasome from the archaeonT. acidophilumat 3.4A resolution”, Science, vol. 268, pp. 533-539.
Lu et al., 2002, “The global regulator ArcA controls resistance to reactive nitrogen and oxygen intermediates inSalmonella entericaserovar Enteritidis”, Infection and Immunity, vol. 70, pp. 451-461.
Lupas et al., 1997, “Eubacterial proteasomes”, Molecular Biology Reports, 24: 125-131.
Nagy et al., 1997, “Further sequence analysis of the DNA regions with the Rhodococcus 20S proteasome structural genes reveals extensive homologyMycobacterium leprae”, DNA Sequence, vol. 7, pp. 225-228.
Orren et al., 1992, “Post-incision steps of nucleotide excision repair inEscherichia coli”, The Journal of Biological Chemistry, vol. 267, pp. 780-788.
A. Sancar, 1996, “DNA excision repair”, in Annual Review of Biochemistry, vol. 65, pp. 43-81.
Skorvaga et al., 2002, The [beta]-hairpin motif of UvrB is essential for DNA binding, damage processing and UvrC-mediated incisions, The Journal of Biological Chemistry, vol. 277, pp. 1553-1559.
R. H. White, 2001, “Biosynthesis of the methanogenic cofactors”, in Vitamins & Hormones, vol. 61, pp. 299-337.
Akaike, “Role of Free Radicals in Viral Pathogenesis and Mutation,”Rev. Med. Virol. 11(2):87-101 (2001).
Bloom et al., “Tuberculosis: Commentary on a Re-Emergent Killer,”Science257:1055-1064 (1992).
Benaroudj et al., “PAN, the Proteasome-Activating Nucleotidase from Archaebacteria, is a Protein-Unfolding Molecular Chaperone,”Nat. Cell. Biol. 2(11):833-839 (2000).
Bryk et al., “Metabolic Enzymes of Mycobacteria Linked to Antioxidant Defense by a Thioredoxin-Like Protein,”Science295(5557):1037-1077 (2002).
Buchmeier et al., “A Parallel Intraphagosomal Survival Strategy Shared byMycobacterium tuberculosisandSalmonella enterica,” Molec. Microbiol. 35(6):1375-1382 (2000).
Chan et al., “Killing of VirulentMycobacterium tuberculosisby Reactive Nitrogen Intermediates Produced by Activated Murine Macrophages,”J. Exp. Med. 175:1111-1122 (1992).
Chan et al., “Effects of Nitric Oxide Synthase Inhibitors on Murine Infection withMycobacterium tuberculosis,” Infect Immun. 63(2):736-740 (1995).
Choi et al., “Demonstration thatfbiCis required byMycobacterium bovisBCG for Coenzyme F420and FO Biosynthesis,”J. Bacteriol. 184(9):2420-2428 (2002).
Cole et al., “Massive Gene Decay in the Leprosy Bacillus,”Nature409:1007-1011 (2001).
Daley et al., “An Outbreak of Tuberculosis with Accelerated Progression Among Persons Infected with the Human Immunodeficiency Virus. An Analysis Using Restriction-Fragment-Length Polymorphisms,”N. Engl. J. Med. 326(4):231-235 (1992).
Davies K.J., “Degradation of Oxidized Proteins by the 20S Proteasome,”Biochimie83:301-310 (2001).
De Mot et al., “Proteasomes and Other Self-Compartmentalizing Proteases in Prokaryotes,”Trends Microbiol. 7(2):88-92 (1999).
Dye et al., “Consensus Statement. Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country. WHO Global Surveillance and Monitoring Project,”JAMA282(7):677-686 (1999).
Ehrt et al., “Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ andMycobacterium tuberculosis: Signaling roles of Nitric Oxide Synthase-2 and Phagocyte Oxidase,”J. Exp. Med. 194(8):1123-1140 (2001).
Facchetti et al., “Expression of Inducible Nitric Oxide Synthase in Human Granulomas and Histiocytic Reactions,”Am. J. Pathol. 154(1):145-152 (1999).
Forbes et al., “Divalent-Metal Transport by NRAMP Proteins at the Interface of Hose-Pathogen Interactions,”Trends Microbiol. 9(8):397-403 (2001).
Graham et al., “Identification ofMycobacterium tuberculosisRNAs Synthesized in Response to Phagocytosis by Human Macrophages by Selective Capture of Transcribed Sequences (SCOTS),”Proc. Natl. Acad. Sci. USA96:11554-11559 (1999).
Grune et al., “Peroxynitrite Increases the Degradation of Aconitase and Other Cellular Proteins by Proteasome,”J. Biol. Chem. 273(18):10857-10862 (1998).
Hernandez-Pando et al., “Persistence of DNA fromMycobacterium tuberculosisin Superficially Normal Lung Tissue During Latent Infection,”Lancet356:2133-2138 (2000).
Karimova et al., “A Bacterial Two-Hybrid System Based on a Reconstituted Signal Transduction Pathway,”Proc. Natl. Acad. Sci. USA95:5752-5756 (1998).
Kaushal et al., “Reduced Immunopathology and Mortality Despite Tissue Persistence in aMycobacterium tuberculosisMutant Lacking Alternative σ Factor, SigH,”Proc. Natl. Acad. Sci. USA99(12):8330-8335 (2002).
Keane et al., “Tubercuolosis Associated with Infliximab, a Tumor Necrosis-Factor α-Neutralizing Agent,”N. Engl. M. Med. 345(15):1098-1104 (2001).
Kisselev et al., “Proteasome Inhibitors: from Research Tools to Drug Candidates,”Chem. Biol. 8(8):739-758 (2001).
Knipfer et al., “Inactivation of the 20S Proteasome inMycobacterium smegmatis,” Mol. Microbiol. 25(2):375-383 (1997).
Langer, T. “AAA Proteases: Cellular Machines for Degrading Membrane Proteins,”Trends in Biol. Sci. 25:247-251 (2000).
Lienhardt et al., Estimation of the Impact of the Human Immunodeficiency Virus Infection on Tuberculosis: Tuberculosis Risks Re-visited?Int. J. Tuberc. Lung Dis. 1(3):196-203 (1997).
Long et al., “Mycobacteriocidal Action of Exogenous Nitric Oxide,”Antimicrob. Agents Chemother. 43(2):403-405 (1999).
MacMicking et al., “Altered Responses to Bacterial Infection and Endotoxic Shock in Mice Lacking Inducible Nitric Oxide Synthase,”Cell81:641-650 (1995).
MacMicking et al., “Nitric Oxide and Macrophage Function,”Annu. Rev. Immunol. 15:323-350 (1997).
MacMicking et al., “Identification of Nitric
Darwin Katerina Heran
Nathan Carl F.
Cornell Research Foundation Inc.
Moore William W.
Nashed Nashaat T.
Nixon & Peabody LLP
LandOfFree
Prokaryotic proteasomal proteases of Mycobacterium... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prokaryotic proteasomal proteases of Mycobacterium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prokaryotic proteasomal proteases of Mycobacterium... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3839942